Foreite Labs在11月19日将其Alumis股份增加了8.1%,在损失和收入损失中以6.56美元购买了190 500股股票。 Foresite Labs boosted its Alumis stake by 8.1% on Nov. 19, buying 190,500 shares at $6.56 amid a loss and revenue miss.

2025年11月19日,Alumis(NASDAQ:ALMS)的主要股东Foresite Labs购买了190 500股,每股656美元,股份增加了8.1%,使总所有权达到254万股,价值1 670万美元。 On November 19, 2025, Foresite Labs, a major shareholder of Alumis (NASDAQ:ALMS), purchased 190,500 shares at $6.56 per share, increasing its stake by 8.1%, bringing total ownership to 2.54 million shares valued at $16.7 million. 此前曾于11月17日和18日购买过这些物品。 This follows earlier purchases on November 17 and 18. Alumis的库存上升到6.57美元,交易量很高。 Alumis stock rose to $6.57 with high trading volume. 该公司报告的季度损失为每股1.06美元、缺失估计数和收入207万美元,低于预测。 The company reported a quarterly loss of $1.06 per share, missing estimates, and revenue of $2.07 million, below forecasts. 分析师持有“机动购买”共识和19.20美元的目标价格,前景参差不齐。 Analysts maintain a mixed outlook with a "Moderate Buy" consensus and a $19.20 target price.